Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Mar;43(1):99-125.
doi: 10.1016/j.ccm.2021.12.002.

Allergic Bronchopulmonary Aspergillosis

Ritesh Agarwal  1 , Valliappan Muthu  2 , Inderpaul S Sehgal  2 , Sahajal Dhooria  2 , Kuruswamy T Prasad  2 , Ashutosh N Aggarwal  2
Affiliations
Review

Allergic Bronchopulmonary Aspergillosis

Ritesh Agarwal et al. Clin Chest Med. 2022 Mar.

Abstract

Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic disorder caused by immune reactions against Aspergillus fumigatus. ABPA most commonly complicates the course of patients with poorly controlled asthma. Patients commonly present with uncontrolled asthma, fleeting pulmonary opacities, and bronchiectasis. Pathogenetically, ABPA is characterized by the persistence of A. fumigatus in the airways and an exaggerated type-2 immune response. The interest in ABPA stems from the fact that bronchiectasis in ABPA can be prevented if the disorder is diagnosed timely and treated appropriately. Herein, we summarize the current concepts in the epidemiology, pathogenesis, diagnosis, and treatment of ABPA.

Keywords: ABPA; ABPM; Aspergillus; Asthma; allergic bronchopulmonary mycosis; cystic fibrosis.

PubMed Disclaimer

Publication types

MeSH terms